A consortium comprising Asia-focused private equity firm FountainVest Partners and China-based global investment firm Primavera Capital Group has acquired 24.78 per cent stake in Shanghai-listed LBX Pharmacy from EQT Greater China II Fund, according to a statement.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
